Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey-Reference-Cited by-同舟云学术

Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey

Published:2011-04 Issue:2 Volume:11 Page:204-211
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Schmidt Christian,Fetscher Sebastian,Görg Christian,Kornek Peter,Nusch Arnd,Kegel Thomas,Kellermann Lenka,Hiddemann Wolfgang,Fingerle-Rowson Guenter,Dreyling Martin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference16 articles.

1. Epidemiology of lymphomas;Baris;Curr Opin Oncol,2000

2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues,2008

3. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997;Harris;J Clin Oncol,1999

4. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up;Dreyling;Ann Oncol,2009

5. Epidemiologie maligner Lymphome;Hölscher,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of relapsed follicular lymphoma;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Follicular Lymphoma in Young Adults: Study from a Regional Cancer Center in South India;South Asian Journal of Cancer;2021-04

3. Mantle cell lymphoma: therapeutic options in transplant-ineligible patients;Leukemia & Lymphoma;2019-04-25

4. Altered treatment of chronic lymphocytic leukemia in Germany during the last decade;Annals of Hematology;2016-03-29

5. Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia;Leukemia & Lymphoma;2015-11-20